首页> 外文期刊>Current opinion in urology >Postpercutaneous nephrolithotomy bleeding: Aetiology and management
【24h】

Postpercutaneous nephrolithotomy bleeding: Aetiology and management

机译:后期肾功能亢进出血:治疗和管理

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose Of review: Postpercutaneous nephrolithotomy (PCNL) bleeding is the most dreaded complication following PCNL. In this article, we refer to risk factors contributing to post-PCNL bleeding and the criteria to decide the line of management in such cases. We further discuss the treatment algorithm for the management of the complication. RECENT FINDINGS: A perfect puncture is a 'key' to avoid post-PNL bleeding. Superselective angioembolization (SAE) is an efficacious and well tolerated method of controlling post-PCNL bleeding, and the success rate of SAE is found to be greater than 80%. Pseudoaneurysm is the commonest finding of SAE, which is responsible for post-PCNL bleeding. A recent study suggested that multiple percutaneous accesses, more than two bleeding sites identified during renal angiography, and the use of gelatine sponge alone as the embolic material were high-risk factors for the failure of SAE. A significant number of patients experience postinfarction syndrome in varying degree of severity after SAE. SUMMARY: Post-PCNL bleeding is a life-threatening complication. Most of the post-PCNL bleeds subside with conservative management, and SAE is an effective means of controlling post-PCNL bleeding. A skilled interventionist can achieve successful control of bleeding with a variety of agents available. Multiple punctures and evidence of more than two lesions predict high risk of failure of SAE.
机译:审查目的:后期肾功能亢进(PCN1)出血是PCNL后最可怕的并发症。在本文中,我们指的是有助于PCNL出血的危险因素以及在这种情况下决定管理线的标准。我们进一步讨论了管理并发症的治疗算法。最近的发现:完美的穿刺是一个“关键”,以避免PNL出血。超选择性血栓栓塞(SAE)是控制后PCN1渗出的有效且良好的耐受性方法,并且SAE的成功率大于80%。伪肿瘤是SAE的最常见的发现,它负责Pypnl出血。最近的一项研究表明,在肾血管造影期间鉴定出多个经皮的进入,以及单独使用明胶海绵的出血位点是栓塞材料的高风险因素。大量患者在SAE后的变异程度上变化综合征的经验。摘要:PCNL出血是危及生命的并发症。大多数PCNL后泄漏和保守管理缓解,SAE是控制后PCNL出血的有效手段。熟练的介入者可以成功地使用各种可用的药剂进行出血。多个刺破和两个以上病变的证据预测了SAE失效的高风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号